Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 68

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Thymol Inhibits Biofilm Formation, Eliminates Pre-Existing Biofilms, and Enhances Clearance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Mouse Peritoneal Implant Infection Model

Yuan, Zhongwei, Dai, Yuyun, Ouyang, Ping, Rehman, Tayyab, Hussain, Sajjad, Zhang, Tianyi, Yin, Zhongqiong, Fu, Hualin, Lin, Juchun, He, Changliang, Lv, Cheng, Liang, Xiaoxia, Shu, Gang, Song, Xu, Li, Lixia, Zou, Yuanfeng, Yin, Lizi·2020·Microorganisms

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a common human pathogen that causes several difficult-to-treat infections, including biofilm-associated infections. The biofilm-forming ability of S. aureus plays a pivotal role in its resistance to most currently available antibiotics, including vancomycin, which is the first-choice drug for treating MRSA infections. In this study, the ability of thymol (a monoterpenoid phenol isolated from plants) to inhibit biofilm formation and to eliminate mature biofilms, was assessed. We found that thymol could inhibit biofilm formation and remove mature biofilms by inhibiting the production of polysaccharide intracellular adhesin (PIA) and the release of extracellular DNA (eDNA). However, cotreatment with thymol and vancomycin was more effective at eliminating MRSA biofilms, in a mouse infection model, than monotherapy with vancomycin. Comparative histopathological analyses revealed that thymol reduced the pathological changes and inflammatory responses in the wounds. Assessments of white blood cell counts and serum TNF-α and IL-6 levels showed reduced inflammation and an increased immune response following treatment with thymol and vancomycin. These results indicate that combinatorial treatment with thymol and vancomycin has the potential to serve as a more effective therapy for MRSA biofilm-associated infections than vancomycin monotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/microorganisms8010099

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 66

  1. Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
  2. Foster, 2014, Adhesion, invasion, and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  3. Amalaradjou, 2014, Antibiofilm effect of octenidine hydrochloride on Staphylococcus aureus, MRSA and VRSA, Pathogens, 3, 404, 10.3390/pathogens3020404 · doi:10.3390/pathogens3020404
  4. Rodvold, 2014, Methicillin-resistant Staphylococcus aureus therapy: Past, present, and future, Clin. Infect. Dis., 58, S20, 10.1093/cid/cit614 · DOI · Paper page
  5. Dryden, 2008, Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: Epidemiology, risk factors, and presentation, Surg. Infect., 9, s3, 10.1089/sur.2008.066.supp · DOI
  6. Li, 2018, Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections, J. Orthop. Res., 36, 22, 10.1002/jor.23656 · DOI · Paper page
  7. Friedman, 2016, The negative impact of antibiotic resistance, Clin. Microbiol. Infect., 22, 416, 10.1016/j.cmi.2015.12.002 · DOI · Paper page
  8. Kiedrowski, 2011, New approaches for treating staphylococcal biofilm infections, Ann. N. Y. Acad. Sci., 1241, 104, 10.1111/j.1749-6632.2011.06281.x · DOI · Paper page
  9. Patel, 2007, The challenge of treating biofilm-associated bacterial infections, Clin. Pharm., 82, 204
  10. Mohammed, 2018, Vision for medicine: Staphylococcus aureus biofilm war and unlocking key’s for anti-biofilm drug development, Microb. Pathog., 123, 339, 10.1016/j.micpath.2018.07.002 · DOI
  11. Chung, 2014, Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus, Pathog. Dis., 70, 231, 10.1111/2049-632X.12141 · DOI · Paper page
  12. Flemming, 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
  13. Pozzi, 2008, A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB, J. Bacteriol., 190, 3835, 10.1128/JB.00167-08 · DOI · Paper page
  14. Boles, 2011, Staphylococcal biofilm disassembly, Trends Microbiol., 19, 449, 10.1016/j.tim.2011.06.004 · DOI · Paper page
  15. Yoshii, 2017, Norgestimate inhibits staphylococcal biofilm formation and resensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics, NPJ Biofilms Microbiomes, 3, 18, 10.1038/s41522-017-0026-1 · DOI
  16. Costerton, 1999, Bacterial biofilms: A common cause of persistent infections, Science, 284, 5418, 10.1126/science.284.5418.1318 · DOI · Paper page
  17. Singh, 2010, Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms, J. Antimicrob. Chemother., 65, 1955, 10.1093/jac/dkq257 · DOI · Paper page
  18. Mu, 2014, Chitosan improves anti-biofilm efficacy of gentamicin through facilitating antibiotic penetration, Int. J. Mol. Sci., 15, 22296, 10.3390/ijms151222296 · DOI
  19. Barbieri, 2017, Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity, Microbiol. Res., 196, 44, 10.1016/j.micres.2016.12.003 · DOI · Paper page
  20. Subramani, 2017, Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens, 3 Biotech, 7, 172, 10.1007/s13205-017-0848-9 · DOI · Paper page
  21. Luna, A., Lema-Alba, R.C., Dambolena, J.S., Zygadlo, J.A., Labaque, M.C., and Marin, R.H. (2017). Thymol as natural antioxidant additive for poultry feed: Oxidative stability improvement. Poult. Sci., 96. · DOI
  22. Marchese, 2016, Antibacterial and antifungal activities of thymol: A brief review of the literature, Food Chem., 210, 402, 10.1016/j.foodchem.2016.04.111 · DOI · Paper page
  23. Zhou, 2019, Thymol mediates bactericidal activity against Staphylococcus aureus by targeting an aldo-keto reductase and consequent depletion of NADPH, J Agric. Food Chem., 67, 8382, 10.1021/acs.jafc.9b03517 · DOI
  24. Yuan, 2018, Antibacterial mechanism of thymol on methicillin-resistant Staphylococcus aureus (MRSA), J. South. China Agric. Univ., 6, 18
  25. McCarthy, 2015, Methicillin resistance and the biofilm phenotype in Staphylococcus aureus, Front. Cell. Infect. Microbiol., 5, 1, 10.3389/fcimb.2015.00001 · DOI · Paper page
  26. Humphreys, 2001, Staphylococcus epidermidis biofilms: Importance and implications, J. Med. Microbiol., 50, 582, 10.1099/0022-1317-50-7-582 · DOI · Paper page
  27. Nethercott, 2013, Molecular characterization of endocarditis-associated Staphylococcus Aureus, J. Clin. Microbiol., 51, 2131, 10.1128/JCM.00651-13 · DOI
  28. Xiang, 2017, Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development, Appl. Microbiol. Biotechnol., 101, 6671, 10.1007/s00253-017-8403-5 · DOI
  29. Chen, Y., Liu, T., Wang, K., Hou, C., Cai, S., Huang, Y., Du, Z., Huang, H., Kong, J., and Chen, Y. (2016). Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS ONE, 11. · DOI · Paper page
  30. Garrett, 2008, Bacterial adhesion and biofilms on surfaces, Prog. Nat. Sci., 18, 1049, 10.1016/j.pnsc.2008.04.001 · DOI · Paper page
  31. Figueiredo, 2017, The role of biofilms in persistent infections and factors involved in ica-independent biofilm development and gene regulation in Staphylococcus aureus, Crit. Rev. Microbiol., 43, 602, 10.1080/1040841X.2017.1282941 · DOI
  32. Joo, 2012, Molecular basis of in vivo biofilm formation by bacterial pathogens, Chem. Biol., 19, 1503, 10.1016/j.chembiol.2012.10.022 · DOI · Paper page
  33. Cue, 2012, Genetic regulation of the intercellular adhesion locus in staphylococci, Front. Cell. Infect. Microbiol., 2, 38, 10.3389/fcimb.2012.00038 · DOI · Paper page
  34. Coelho, 2008, Agr RNAIII divergently regulates glucose-induced biofilm formation in clinical isolates of Staphylococcus aureus, Microbiology, 154, 3480, 10.1099/mic.0.2007/016014-0 · DOI
  35. Beenken, 2004, Global gene expression in Staphylococcus aureus biofilms, J. Bacteriol., 186, 4665, 10.1128/JB.186.14.4665-4684.2004 · DOI · Paper page
  36. Tormo, 2005, SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development, J. Bacteriol., 187, 2348, 10.1128/JB.187.7.2348-2356.2005 · DOI · Paper page
  37. Valle, 2003, SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus, Mol. Microbiol., 48, 1075, 10.1046/j.1365-2958.2003.03493.x · DOI · Paper page
  38. Speziale, 2014, Protein-based biofilm matrices in Staphylococci, Front. Cell. Infect. Microbiol., 4, 171, 10.3389/fcimb.2014.00171 · DOI · Paper page
  39. Houston, 2011, Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype, Infect. Immun., 79, 1153, 10.1128/IAI.00364-10 · DOI · Paper page
  40. Okshevsky, 2015, Extracellular DNA as a target for biofilm control, Curr. Opin. Biotechnol., 33, 73, 10.1016/j.copbio.2014.12.002 · DOI · Paper page
  41. Kaplan, 2012, Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci, J. Antibiot., 65, 73, 10.1038/ja.2011.113 · DOI · Paper page
  42. Kouidhi, 2015, Drug resistance of bacterial dental biofilm and the potential use of natural compounds as alternative for prevention and treatment, Microb. Pathog., 80, 39, 10.1016/j.micpath.2015.02.007 · DOI · Paper page
  43. Arciola, 2015, Biofilm-based implant infections in orthopaedics, Adv. Exp. Med. Biol., 830, 29, 10.1007/978-3-319-11038-7_2 · DOI · Paper page
  44. Costerton, 2005, Biofilm in implant infections: Its production and regulation, Int. J. Artif. Organ., 28, 1062, 10.1177/039139880502801103 · DOI · Paper page
  45. Yao, 2018, Protective effects of thymol on LPS-induced acute lung injury in mice, Microb. Pathog., 116, 8, 10.1016/j.micpath.2017.12.065 · DOI
  46. Xu, 2017, Intraperitoneal vancomycin plus either oral moxifloxacin or intraperitoneal ceftazidime for the treatment of peritoneal dialysis−related peritonitis: A randomized controlled pilot study, Am. J. Kidney Dis., 70, 30, 10.1053/j.ajkd.2016.11.008 · doi:10.1053/j.ajkd.2016.11.008
  47. Eto, D., Lao, C., DiToro, D., Barnett, B., Escobar, T.C., Kageyama, R., Yusuf, I., and Crotty, S. (2011). IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE, 6. · DOI · Paper page
  48. Rey, 2016, Graft-derived IL-6 amplifies proliferation and survival of effector T cells that drive alloimmune-mediated vascular rejection, Transplantation, 100, 1
  49. Wang, 2018, Thymol alleviates lipopolysaccharide-stimulated inflammatory response via downregulation of RhoA-mediated NF-κB signalling pathway in human peritoneal mesothelial cells, Eur. J. Pharmacol., 833, 210, 10.1016/j.ejphar.2018.06.003 · DOI
  50. Yuan, 2019, The antibacterial mechanism of oridonin against methicillin-resistant Staphylococcus aureus (MRSA), Pharm. Biol., 57, 710, 10.1080/13880209.2019.1674342 · DOI
  51. Laudadio, 2019, Natural alkaloid berberine activity against Pseudomonas aeruginosa MexXY-mediated aminoglycoside resistance: In silico and in vitro studies, J. Nat. Prod., 7, 1935, 10.1021/acs.jnatprod.9b00317 · DOI
  52. Brilhante, 2019, Terpinen-4-ol inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents, Future Microbiol., 14, 1221, 10.2217/fmb-2019-0146 · DOI
  53. Qian, 2015, Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus, Int. J. Med. Microbiol., 6, 501, 10.1016/j.ijmm.2015.05.001 · DOI
  54. Zhang, 2017, Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and alpha-hemolysin, Front. Microbiol., 8, 1715, 10.3389/fmicb.2017.01715 · DOI
  55. Sun, 2016, Pseudomonas fluorescens filamentous hemagglutinin, an iron-regulated protein, is an important virulence factor that modulates bacterial pathogenicity, Front. Microbiol., 7, 1320, 10.3389/fmicb.2016.01320 · DOI
  56. Saising, 2012, Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms, Antimicrob. Agents Chemother., 56, 5804, 10.1128/AAC.01296-12 · DOI
  57. Chan, 2011, Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase, J. Ethnopharmacol., 137, 767, 10.1016/j.jep.2011.06.039 · DOI · Paper page
  58. Freeman, 1989, New method for detecting slime production by coagulase negative staphylococci, J. Clin. Pathol., 42, 872, 10.1136/jcp.42.8.872 · DOI · Paper page
  59. Podbielska, 2010, Slime production by Staphylococcus aureus and Staphylococcus epidermidis strains isolated from patients with diabetic foot ulcers, Arch. Immunol. Exp., 58, 321, 10.1007/s00005-010-0079-9 · DOI
  60. Rice, 2007, The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus, Proc. Natl. Acad. Sci. USA, 104, 8113, 10.1073/pnas.0610226104 · DOI · Paper page
  61. Ouyang, P., He, X., Yuan, Z.W., Yin, Z.Q., Fu, H., Lin, J., He, C., Liang, X., Lv, C., and Shu, G. (2018). Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A. Toxins, 10. · DOI
  62. Thomas, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
  63. Christensen, 2012, Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model, J. Antimicrob. Chemother., 67, 1198, 10.1093/jac/dks002 · DOI · Paper page
  64. Luo, J., Dong, B., Wang, K., Cai, S., Liu, T., Cheng, X., Lei, D., Chen, Y., Li, Y., and Kong, J. (2017). Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. PLoS ONE, 12. · DOI · Paper page
  65. Inoue, 2017, Inhibition of biofilm formation on iodine-supported titanium implants, Methods Int. Orthop., 41, 1093, 10.1007/s00264-017-3477-3 · doi:10.1007/s00264-017-3477-3
  66. Feldman, 2014, Tissue processing and hematoxylin and eosin staining, Methods Mol. Biol., 1180, 31, 10.1007/978-1-4939-1050-2_3 · DOI · Paper page

Cited by

See all 68

Metadata

Authors
Yuan, Z., Dai, Y., Ouyang, P., Rehman, T., Hussain, S., Zhang, T., Yin, Z., Fu, H., Lin, J., He, C., Lv, C., Liang, X., Shu, G., Song, X., Li, L., Zou, Y., & Yin, L.
Venue
Microorganisms
Publisher
MDPI AG
Published
2020-01-10
Volume
8
Issue
1
Pages
99
ISSN
2076-2607
Cited by
68
References
1
Language
en
Funders
  • National Natural Science Foundation of China (31702284)
  • Double subject construction plan of Sichuan Agriculture University (03571444)
  • Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System (CARS-SVDIP)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.